Dr. Lal PathLabs Limited (NSE:LALPATHLAB)

Market Cap	275.69B +21.9%
Revenue (ttm)	27.63B +12.2%
Net Income	5.05B +3.6%
EPS	30.20 +3.4%
Shares Out	167.11M
PE Ratio	54.63
Forward PE	46.69
Dividend	16.00 (0.97%)
Ex-Dividend Date	Jun 25, 2026

Volume	938,989
Average Volume	813,102
Open	1,637.90
Previous Close	1,649.80
Day's Range	1,629.30 - 1,698.00
52-Week Range	1,272.60 - 1,770.00
Beta	0.11
RSI	70.98
Earnings Date	Apr 30, 2026

About Dr. Lal PathLabs

Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers phlebotomist training programs. The company was founded in 1949 and is based in Gurugram, India.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1949
• Employees: 4,980
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: LALPATHLAB

Financial Performance

In fiscal year 2026, Dr. Lal PathLabs's revenue was 27.63 billion, an increase of 12.25% compared to the previous year's 24.61 billion. Earnings were 5.05 billion, an increase of 3.63%.